Research Publications by Mark Yarchoan
Total publications: 8
- Clinical Guideline for the Diagnosis and Treatment of Fibrolamellar Carcinoma (FLC) — Hepatology, March 18, 2026
- A Therapeutic Peptide Vaccine for Fibrolamellar Hepatocellular Carcinoma: A Phase 1 Trial — Nature Medicine, November 24, 2025
- Serum Procalcitonin: A Novel Tumor Biomarker for Diagnosis and Follow-Up in Fibrolamellar Hepatocellular Carcinoma — MedRxiv, November 20, 2025
- DNAJ-PKAc induces metabolic wiring and enhanced glutamine flux in fibrolamellar HCC — Journal of Hepatology, November 6, 2025
- Proteo-metabolomics and patient tumor slice experiments point to amino acid centrality for rewired mitochondria in fibrolamellar carcinoma — Cell Reports Medicine, August 28, 2024
- DNAJB1-PRKACA fusion neoantigens elicit rare endogenous T cell responses that potentiate cell therapy for fibrolamellar carcinoma — Cell Reports Medicine, March 19, 2024
- Clinical Outcomes in Fibrolamellar Hepatocellular Carcinoma Treated with Immune Checkpoint Inhibitors — Cancers, October 30, 2022
- Targeting BCL-XL in fibrolamellar hepatocellular carcinoma — JCI Insight, September 8, 2022
This list represents the complete set of research publications authored or co‑authored by Mark Yarchoan that are listed on this website.